ASCO 2016 | Improved overall survival in lung cancer patients using Moovcare compared to standard modalities
Press brief by Fabrice Denis, MD, PhD of the Jean Bernard Center, Le Mans, France, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Get great new content delivered to your inboxSign up
TTFields as an anti-mitotic therapy
The LUNAR study: TTFields for treating NSCLC
The STELLAR study: TTFields for malignant pleural mesothelioma
Afatinib for advanced EGFRm-positive NSCLC
TKIs to treat EGFRm-positive NSCLC